Figure 3. Kaplan Meier survival curve showing patient survival for the presence or absence of HLA-C2 allele in the recipient.

The presence of an HLA-C2 allele in the recipient was associated with a significant improvement in patient survival (10-year survival: 88.5% versus 80.4%).